METABIOMED.CO.,LTD Q3 revenue KRW 24.7 billion, operating profit KRW 2.0 billion, net loss KRW 1.4 billion
AI summary · Not investment advice
Metabiomed sold KRW 24.7 billion in Q3 and earned KRW 2.0 billion from its main business, down 60.9% from a year earlier and down 68.3% from the previous quarter.
Operating profit · 3 months
KRW 2.0 billion
Key facts
- Revenue (3 months)
- KRW 24.7 billion
- Net income (3 months)
- KRW -1.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 23.5 billion
- Revenue (year to date)
- KRW 76.1 billion
- Operating profit (prior-year 3 months)
- KRW 5.1 billion
- Operating profit (year to date)
- KRW 13.1 billion
- Net income (prior-year 3 months)
- KRW 4.5 billion
- Net income (year to date)
- KRW 9.2 billion
Commentary
AI commentary · Not investment advice
What happened
Metabiomed reported its consolidated results for the 3rd quarter of 2026. Sales for the 3 months were KRW 24.66 billion. That is 4.8% above the same 3 months a year earlier (KRW 23.53 billion) and 8.6% below the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 1.99 billion. That is 60.9% below the same period a year earlier (KRW 5.08 billion). It is also 68.3% below the previous quarter.
What changes for shareholders
Net income (final profit after taxes and all other items) for the 3 months was a loss of KRW 1.45 billion. A year earlier it was a profit of KRW 4.46 billion, so it turned to a loss. The previous quarter was also a profit.
For the year to date (Jan 1 to Sep 30), sales were KRW 76.07 billion. Operating profit was KRW 13.11 billion. Net income was KRW 9.25 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
M